Discovery Park comment on the Government's Spending Review Announcement today
Following today's Spending Review announcement of investment in life science manufacturing, Discovery Park has issued the following comment:Mayer Schreiber, CEO, Discovery Park in Kent, one of the UK’s fastest-growing communities of life science business, including Pfizer, Viatris and Concept Life Sciences said: “We are delighted by the Chancellor’s announcement of £1.4 billion of funding into the new Global Britain Investment Fund in today’s annual Spending Review, including £354 million for life sciences manufacturing. It is recognition of the UK’s exceptional record in life sciences innovation and of the sector’s potential to further accelerate medical advances, improve lives, create high quality jobs, and boost the economy.
As the Chancellor said the pandemic had shown how important innovative research and development is in delivering new, life-saving treatments and at Discovery Park we are focussed on enabling life science start-ups to develop and scale on-site. On our 220 acre campus we have lab and manufacturing facilities ready to occupy, with land to expand coupled with a thriving scientific community and business support services.”